What is Zacks Research’s Forecast for ACHC FY2024 Earnings?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at Zacks Research lowered their FY2024 earnings estimates for Acadia Healthcare in a research report issued on Wednesday, November 13th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings per share of $3.37 for the year, down from their previous forecast of $3.46. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.71 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.94 EPS, Q1 2026 earnings at $0.88 EPS, Q2 2026 earnings at $0.99 EPS, Q3 2026 earnings at $1.07 EPS and FY2026 earnings at $3.99 EPS.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share.

Several other equities analysts have also recently issued reports on the company. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 14th. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Barclays reduced their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $83.33.

Acadia Healthcare Trading Down 0.1 %

NASDAQ:ACHC opened at $37.09 on Monday. The stock has a fifty day moving average price of $56.48 and a 200 day moving average price of $65.14. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The firm has a market cap of $3.45 billion, a PE ratio of 12.16, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently modified their holdings of the company. Blue Trust Inc. raised its position in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Acadia Healthcare during the second quarter worth about $59,000. Covestor Ltd increased its position in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after acquiring an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare during the 3rd quarter valued at approximately $86,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.